Apoptosis induced by sodium butyrate treatment increases immunogenicity of a rat colon tumor cell line

Apoptosis

Volumn 2, Issue 4, 1997, Pages 403-412

  Boisteau, O ^a   Gautier, F ^a   Cordel, S ^a   Henry, F ^a   Harb, J ^a   Douillard, J Y ^a,b   Vallette, F M ^a   Meflah, K ^a   Gregoire M ^a  

^a INSTITUT DE BIOLOGIE   (France)

^b Ctr Reg la Lutte Contre le Cancer   (France)

Author keywords

Apoptotic bodies; Sodium butyrate; Therapeutics; Tumour vaccine

Indexed keywords

EID: 0001348180     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026461825570     Document Type: Article

References (15)

1. Stevenson FK. Update on tumor vaccines. Int J Clin Lab Res 1992; 22: 84-89.
2. Beatty JD. Immunotherapy of colorectal cancer. Cancer 1992; 70: 1425-1433.
3. Moertel CG. Accomplishments in surgical adjuvant therapy for large bowel cancer. Cancer 1992; 5(Suppl 70): 1364-1371.
4. Perrin P, Cassagnau E, Burg C, et al. An interleukine 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis. Gastroenterology 1994; 107: 1697-1708.
5. Patry Y, Douillard JY, Meflah K, LePendu J. Immunization against a rat colon carcinoma by sodium butyrate-treated cells but not Interleukin 2-secreting cells. Gastroenterology 1995; 109: 1555-1565.
6. Gamet L, Daviaud D, Denis-Pouxviel C, Remesy C, Murat JC. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29. Int J Cancer 1992; 52: 286-289.
7. Hague A, Elder DJE, Hicks DJ, Paraskeva C. Apoptosis in colorectal tumour cells induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 1995; 60: 400-406.
8. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995; 182: 1625-1634.
9. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-1330.
10. Casiano CA, Martin SJ, Green DR, Tan EN. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med 1996; 184: 765-770.
11. Dearden-Badet MT, Pelletier H, Caignard A, Martin F. In vitro proliferative response of spleen lymphocytes from rats bearing progressive or regressive tumors induced by cell variants of a syngeneic colon carcinoma. Int J Cancer 1989; 43: 334-339.
12. Blottière HM, Menoret A, Burg C, Douillard JY, LePendu J. Identification and characterization of a rat protein (P105) auto-antigenic in rats bearing a progressive syngeneic colon carcinoma. Int J Cancer 1992; 50: 315-320.
13. Savill JS, Fadok V, Henson P, Haslett C. Phagocytotic recognition of cells undergoing apoptosis. Immunology Today 1993; 14: 131-136.
14. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann S, Klatzmann D. Regression of established macroscopic liver metastasis after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 1993; 90: 7024-7028.
15. Chen S, Chen XHL, Wang Y, et al. Combination gene therapy for liver metastatic of colon carcinoma in vivo. Proc Natl Acad Sci USA 1995; 92: 2577-2581.